Particle.news

Download on the App Store

Wearable HRV Biofeedback Patch Linked to 64% Lower Daily Substance Use in Phase 2 Trial

The eight-week study enrolled adults in their first year of abstinence-based recovery, using twice-daily self-reports.

Overview

  • Researchers at Mass General Brigham randomized about 115 adults to standard care with the Lief HRVB Smart Patch or standard care alone for eight weeks.
  • The device monitored heart rate variability to detect stress or craving and prompted brief paced-breathing via app vibrations and AI-driven cues.
  • Participants assigned to the device reported fewer cravings and lower negative affect, whereas the control group showed increases in negative affect and cravings.
  • Use of the intervention required wearing the patch roughly eight hours per day with at least 10 minutes of scheduled practice plus prompted sessions logged on smartphones.
  • Findings were published in JAMA Psychiatry with funding from NIDA and NIAAA, and the authors disclosed industry ties and called for larger, longer trials to assess durability and generalizability.